{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:38:03Z","timestamp":1786991883953,"version":"build-2736575974"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jconrel.2025.113602","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:56:20Z","timestamp":1741175780000},"page":"113602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Surface-coated silica microparticles: In vitro and ex vivo evaluation of a preclinical extended release platform conceived for intravitreal injection"],"prefix":"10.1016","volume":"381","author":[{"given":"Marco","family":"Block","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Grube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"G\u00f6pferich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Saal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blessing C.","family":"Ilochonwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"C\u00e1rcamo-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remko A.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Deanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brennan J.","family":"Walder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113602_bb0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/pharmaceutics15010122","article-title":"Current treatments and innovations in diabetic retinopathy and diabetic macular edema","volume":"15","author":"Gonzalez-Cortes","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113602_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1199922","article-title":"Rethinking the potential and necessity of drug delivery systems in neovascular age-related macular degeneration therapy","volume":"11","author":"Huang","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.113602_bb0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-017-0943-1","article-title":"Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies","volume":"14","author":"Rivera","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jconrel.2025.113602_bb0020","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.jconrel.2025.113602_bb0030","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.drudis.2019.05.031","article-title":"Recent advances in intraocular sustained-release drug delivery devices","volume":"24","author":"Cao","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2025.113602_bb0035","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":"Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","volume":"121","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2025.113602_bb0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/bioengineering11020179","article-title":"Seeing the future: a review of ocular therapy","volume":"11","author":"Whalen","year":"2024","journal-title":"Bioengineering"},{"key":"10.1016\/j.jconrel.2025.113602_bb0045","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/pharmaceutics12080703","article-title":"Intravitreal dexamethasone implant as a sustained release drug delivery device for the treatment of ocular diseases: a comprehensive review of the literature","volume":"12","author":"Iovino","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113602_bb0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijpharm.2015.05.071","article-title":"An injectable thermosensitive polymeric hydrogel for sustained release of Avastin\u00ae to treat posterior segment disease","volume":"490","author":"Xie","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113602_bb0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.4.2.5","article-title":"Injectable chemically crosslinked hydrogel for the controlled release of bevacizumab in vitreous: a 6-month in vivo study","volume":"4","author":"Yu","year":"2015","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.113602_bb0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jconrel.2020.07.031","article-title":"Intravitreal hydrogels for sustained release of therapeutic proteins","volume":"326","author":"Ilochonwu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113602_bb0065","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1038\/s41598-019-43613-9","article-title":"A novel 3D in vitro platform for pre-clinical investigations in drug testing, gene therapy, and immunooncology","volume":"9","author":"Candini","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.113602_bb0070","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/mi13020277","article-title":"3D bioprinting of an in vitro model of a biomimetic urinary bladder with a contract-release system","volume":"13","author":"Chae","year":"2022","journal-title":"Micromachines"},{"key":"10.1016\/j.jconrel.2025.113602_bb0075","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/nprot.2013.135","article-title":"Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice","volume":"8","author":"Lambert","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2025.113602_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/iovs.63.9.11","article-title":"Animal models of choroidal neovascularization: a systematic review","volume":"63","author":"Fabian-Jessing","year":"2022","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2025.113602_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.crmeth.2021.100125","article-title":"An intravitreal implant injection method for sustained drug delivery into mouse eyes","author":"Sun","year":"2021","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.jconrel.2025.113602_bb0090","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejpb.2020.05.005","article-title":"Preclinical challenges for developing long acting intravitreal medicines","volume":"153","author":"Awwad","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.113602_bb0095","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejpb.2014.12.005","article-title":"Sustained intravitreal delivery of connexin43 mimetic peptide by poly(d,l-lactide-co-glycolide) acid micro- and nanoparticles \u2013 closing the gap in retinal ischaemia","volume":"95","author":"Chen","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.113602_bb0100","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.biopha.2018.08.092","article-title":"Effect of nanoencapsulation using poly (lactide-co-glycolide) (PLGA) on anti-angiogenic activity of bevacizumab for ocular angiogenesis therapy","volume":"107","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2025.113602_bb0105","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.addr.2008.03.017","article-title":"Porous silicon in drug delivery devices and materials","volume":"60","author":"Anglin","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113602_bb0110","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jps.20999","article-title":"Mesoporous silicon in drug delivery applications","volume":"97","author":"Salonen","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.113602_bb0115","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.2147\/IJN.S71925","article-title":"Silica nanoparticles increase human adipose tissue-derived stem cell proliferation through ERK1\/2 activation","volume":"10","author":"Kim","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.113602_bb0120","series-title":"Inorganic Frameworks as Smart Nanomedicines","first-page":"1","author":"Karaman","year":"2018"},{"key":"10.1016\/j.jconrel.2025.113602_bb0125","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41578-021-00385-x","article-title":"Clinical translation of silica nanoparticles","volume":"6","author":"Janjua","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.113602_bb0130","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/bjo.2007.133587","article-title":"Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle","volume":"92","author":"Cheng","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2025.113602_bb0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12633-011-9097-4","article-title":"Medically biodegradable hydrogenated amorphous silicon microspheres","volume":"3","author":"Shabir","year":"2011","journal-title":"Silicon"},{"key":"10.1016\/j.jconrel.2025.113602_bb0140","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7150\/thno.11389","article-title":"Theranostic mesoporous silica nanoparticles biodegrade after pro-survival drug delivery and ultrasound\/magnetic resonance imaging of stem cells","volume":"5","author":"Kempen","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.113602_bb0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.exer.2013.09.001","article-title":"Ocular silicon distribution and clearance following intravitreal injection of porous silicon microparticles","volume":"116","author":"Nieto","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2025.113602_bb0150","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/cm980243e","article-title":"Inclusion chemistry in periodic mesoporous hosts","volume":"10","author":"Moller","year":"1998","journal-title":"Chem. Mater."},{"key":"10.1016\/j.jconrel.2025.113602_bb0155","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejps.2010.09.002","article-title":"Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica","volume":"41","author":"Speybroeck","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.113602_bb0160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ejpb.2003.12.007","article-title":"Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property","volume":"57","author":"Charnay","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.113602_bb0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.exer.2015.08.007","article-title":"A novel pressed porous silicon-polycaprolactone composite as a dual-purpose implant for the delivery of cells and drugs to the eye","volume":"139","author":"Irani","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2025.113602_bb0170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2014.01.003","article-title":"Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon","volume":"178","author":"Hou","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113602_bb0175","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1167\/iovs.12-11172","article-title":"Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system","volume":"54","author":"Chhablani","year":"2013","journal-title":"Invest. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2025.113602_bb0180","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3390\/nano11061578","article-title":"Sustained in-vivo release of triptorelin acetate from a biodegradable silica depot: comparison to pamorelin\u00ae LA","volume":"11","author":"Forsback","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2025.113602_bb0185","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1021\/cr300399c","article-title":"The sol\u2013gel route to advanced silica-based materials and recent applications","volume":"113","author":"Ciriminna","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.113602_bb0190","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/10717544.2020.1760401","article-title":"Intravitreal safety profiles of sol-gel mesoporous silica microparticles and the degradation product (Si(OH)4)","volume":"27","author":"Sun","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.113602_bb0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/tvst.5.4.11","article-title":"Optical coherence tomography angiography in mice: comparison with confocal scanning laser microscopy and fluorescein angiography","volume":"5","author":"Giannakaki-Zimmermann","year":"2016","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.113602_bb0200","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/0192623321989646","article-title":"Correlations between retinal optical coherence tomography and histopathology in preclinical safety assessment of ocular therapies","volume":"49","author":"Zimmerman","year":"2021","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2025.113602_bb0205","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/eye.2008.30","article-title":"Imaging the vitreous: optical coherence tomography and ultrasound imaging","volume":"22","author":"Restori","year":"2008","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2025.113602_bb0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0021-9797(68)90272-5","article-title":"Controlled growth of monodisperse silica spheres in the micron size range","volume":"26","author":"St\u00f6ber","year":"1968","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2025.113602_bb0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0022-3093(88)90005-1","article-title":"Hydrolysis and condensation of silicates: effects on structure","volume":"100","author":"Brinker","year":"1988","journal-title":"J. Non-Cryst. Solids"},{"key":"10.1016\/j.jconrel.2025.113602_bb0220","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1021\/acs.langmuir.7b01140","article-title":"Unraveling the growth mechanism of silica particles in the St\u00f6ber method: in situ seeded growth model","volume":"33","author":"Han","year":"2017","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2025.113602_bb0225","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s10971-018-4637-7","article-title":"Kinetics of the acid-catalyzed hydrolysis of tetraethoxysilane (TEOS) by 29Si NMR spectroscopy and mathematical modeling","volume":"86","author":"Echeverr\u00eda","year":"2018","journal-title":"J. Sol-Gel Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.113602_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106733","article-title":"Miniaturized screening and performance prediction of tailored subcutaneous extended-release formulations for preclinical in vivo studies","author":"Block","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.113602_bb0235","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1208\/s12249-014-0156-1","article-title":"Preclinical formulations: insight, strategies, and practical considerations","volume":"15","author":"Shah","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2025.113602_bb0240","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.drudis.2022.05.024","article-title":"Targeted drug delivery to the retinal pigment epithelium: untapped therapeutic potential for retinal diseases","volume":"27","author":"Bohley","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2025.113602_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14837","article-title":"Long-acting protein drugs for the treatment of ocular diseases","volume":"8","author":"Ghosh","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113602_bb0250","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","article-title":"Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo","volume":"167","author":"Xu","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113602_bb0255","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1091581815622442","article-title":"Tolerable levels of nonclinical vehicles and formulations used in studies by multiple routes in multiple species with notes on methods to improve utility","volume":"35","author":"Gad","year":"2016","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.jconrel.2025.113602_bb0260","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2147\/OPTH.S297139","article-title":"Novel needle for intravitreal drug delivery: comparative study of needle tip aspirates, injection stream and penetration forces","volume":"15","author":"Lytvynchuk","year":"2021","journal-title":"Clin. Ophthalmol. (Auckl., NZ)"},{"key":"10.1016\/j.jconrel.2025.113602_bb0265","series-title":"The Medical Device R&D Handbook","first-page":"43","author":"Kucklick","year":"2012"},{"key":"10.1016\/j.jconrel.2025.113602_bb0270","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2018.05.025","article-title":"Improved delivery of PLGA microparticles and microparticle-cell scaffolds in clinical needle gauges using modified viscosity formulations","volume":"546","author":"Qutachi","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113602_bb0275","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-4419-9920-7_10","article-title":"Drug product development for the back of the eye","author":"Herrero-Vanrell","year":"2011","journal-title":"AAPS Adv. Pharm. Sci. Ser."},{"key":"10.1016\/j.jconrel.2025.113602_bb0280","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.preteyeres.2013.04.001","article-title":"Nanomedicines for back of the eye drug delivery, gene delivery, and imaging","volume":"36","author":"Kompella","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2025.113602_bb0285","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/nano6070126","article-title":"Quaternized chitosan-capped mesoporous silica nanoparticles as nanocarriers for controlled pesticide release","volume":"6","author":"Cao","year":"2016","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.jconrel.2025.113602_bb0290","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/mrc.2285","article-title":"Swept-frequency two-pulse phase modulation (SWf-TPPM) sequences with linear sweep profile for heteronuclear decoupling in solid-state NMR","volume":"46","author":"Chandran","year":"2008","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.jconrel.2025.113602_bb0295","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1351\/pac200880010059","article-title":"Further conventions for NMR shielding and chemical shifts (IUPAC recommendations 2008)","volume":"80","author":"Harris","year":"2008","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.jconrel.2025.113602_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmr.2022.107231","article-title":"Solid-state chemical-shift referencing with adamantane","volume":"340","author":"Hoffman","year":"2022","journal-title":"J. Magn. Reson."},{"key":"10.1016\/j.jconrel.2025.113602_bb0305","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1021\/ja00535a008","article-title":"Structural studies of silicates by solid-state high-resolution 29Si NMR","volume":"102","author":"Lippmaa","year":"1981","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.113602_bb0310","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1021\/ja00545a056","article-title":"Silicon-29 NMR study of the surface of silica gel by cross polarization and magic-angle spinning","volume":"102","author":"Maciel","year":"1980","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.113602_bb0315","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113602_bb0320","series-title":"<1092> The Dissolution Procedure: Development and Validation","volume":"2021","author":"United States Pharmacopeia National Formulary","year":"2020"},{"key":"10.1016\/j.jconrel.2025.113602_bb0325","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1208\/pt070233","article-title":"Role of surfactant and pH on dissolution properties of fenofibrate and glipizide\u2014a technical note","volume":"7","author":"Jamzad","year":"2006","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2025.113602_bb0330","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s13346-021-01043-z","article-title":"In vitro dissolution testing models of ocular implants for posterior segment drug delivery","volume":"12","author":"Adrianto","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2025.113602_bb0335","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1021\/acs.biomac.2c00383","article-title":"Hyaluronic acid-PEG-based Diels\u2013Alder in situ forming hydrogels for sustained intraocular delivery of bevacizumab","volume":"23","author":"Ilochonwu","year":"2022","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2025.113602_bb0340","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jcis.2020.10.014","article-title":"Renaissance of St\u00f6ber method for synthesis of colloidal particles: new developments and opportunities","volume":"584","author":"Ghimire","year":"2021","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2025.113602_bb0345","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s11095-007-9475-1","article-title":"Pharmaceutical particle engineering via spray drying","volume":"25","author":"Vehring","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2025.113602_bb0350","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0168-3659(02)00066-4","article-title":"Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents","volume":"81","author":"Wang","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113602_bb0355","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/masy.200751215","article-title":"Mesoporous silica applications","volume":"258","author":"Giraldo","year":"2007","journal-title":"Macromol. Symp."},{"key":"10.1016\/j.jconrel.2025.113602_bb0360","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/adfm.200601191","article-title":"Mesoporous silica nanoparticles for drug delivery and biosensing applications","volume":"17","author":"Slowing","year":"2007","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.113602_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2015.11.020","article-title":"Cytotoxicity assessment of porous silicon microparticles for ocular drug delivery","volume":"100","author":"Korhonen","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.113602_bb0370","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s11051-010-9910-9","article-title":"Characterisation of silica nanoparticles prior to in vitro studies: from primary particles to agglomerates","volume":"13","author":"Orts-Gil","year":"2011","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.jconrel.2025.113602_bb0375","series-title":"Characterisation and Chemical Modification of the Silica Surface","author":"Vansant","year":"1995"},{"key":"10.1016\/j.jconrel.2025.113602_bb0380","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1021\/ct2007154","article-title":"The silica\u2013water interface: how the silanols determine the surface acidity and modulate the water properties","volume":"8","author":"Sulpizi","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jconrel.2025.113602_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","article-title":"Biodegradable polymeric nanoparticles as drug delivery devices","volume":"70","author":"Soppimath","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113602_bb0390","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1023\/A:1008603622543","article-title":"Sol-gel carrier systems for controlled drug delivery","volume":"13","author":"B\u00f6ttcher","year":"1998","journal-title":"J. Sol-Gel Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.113602_bb0395","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s41433-020-0809-0","article-title":"Advances in ocular drug delivery systems","volume":"34","author":"Kang-Mieler","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2025.113602_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02980037","article-title":"Control of encapsulation efficiency and initial burst in polymeric microparticle systems","volume":"27","author":"Yeo","year":"2004","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jconrel.2025.113602_bb0405","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0168-3659(02)00137-2","article-title":"Characterization of the initial burst release of a model peptide from poly(d,l-lactide-co-glycolide) microspheres","volume":"82","author":"Wang","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113602_bb0410","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2012.09.028","article-title":"Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)","volume":"64","author":"Siepmann","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113602_bb0415","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2013.04.044","article-title":"Mathematical modeling of drug dissolution","volume":"453","author":"Siepmann","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113602_bb0420","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0168-3659(94)00064-2","article-title":"Modeling monomer release from bioerodible polymers","volume":"33","author":"G\u00f6pferich","year":"1995","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113602_bb0425","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.jbiomech.2008.04.015","article-title":"Rheological properties of the vitreous and the role of hyaluronic acid","volume":"41","author":"Nickerson","year":"2008","journal-title":"J. Biomech."},{"key":"10.1016\/j.jconrel.2025.113602_bb0430","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.exer.2009.03.012","article-title":"Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone","volume":"89","author":"Barcia","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2025.113602_bb0435","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.biomaterials.2017.02.006","article-title":"Evaluation of polyesteramide (PEA) and polyester (PLGA) microspheres as intravitreal drug delivery systems in albino rats","volume":"124","author":"Peters","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113602_bb0440","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0142-9612(02)00445-3","article-title":"In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis","volume":"24","author":"Fischer","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113602_bb0445","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijpharm.2017.02.048","article-title":"Cytotoxicity of polycations: relationship of molecular weight and the hydrolytic theory of the mechanism of toxicity","volume":"521","author":"Monnery","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113602_bb0450","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P","article-title":"Use of chitosan as a biomaterial: studies on its safety and hemostatic potential","volume":"34","author":"Rao","year":"1997","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2025.113602_bb0455","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2004.07.030","article-title":"Transmucosal macromolecular drug delivery","volume":"101","author":"Prego","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113602_bb0460","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jconrel.2005.12.015","article-title":"Chitosan\u2013PEG nanocapsules as new carriers for oral peptide delivery effect of chitosan pegylation degree","volume":"111","author":"Prego","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113602_bb0465","first-page":"3351","article-title":"Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model","volume":"6","author":"Hu","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.113602_bb0470","doi-asserted-by":"crossref","first-page":"7855","DOI":"10.1016\/j.actbio.2013.04.025","article-title":"Chitosan microparticles for delivery of proteins to the retina","volume":"9","author":"Wassmer","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.113602_bb0475","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jddst.2018.12.032","article-title":"Biocompatibility and safety of insulin-loaded chitosan nanoparticles\/ PLGA-PEG-PLGA hydrogel (ICNPH) delivered by subconjunctival injection in rats","volume":"49","author":"Rong","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.113602_bb0480","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00417-008-0813-8","article-title":"Feasibility study of chitosan as intravitreous tamponade material","volume":"246","author":"Yang","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2025.113602_bb0485","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.nano.2008.06.003","article-title":"Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium","volume":"4","author":"Prow","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.113602_bb0490","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exer.1996.0020","article-title":"ARPE-19, a human retinal pigment epithelial cell line with differentiated properties","volume":"62","author":"Dunn","year":"1996","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2025.113602_bb0495","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/pharmaceutics13040560","article-title":"A new bevacizumab carrier for intravitreal administration: focus on stability","volume":"13","author":"Chirio","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113602_bb0500","doi-asserted-by":"crossref","DOI":"10.1111\/aos.15858","article-title":"Tolerability of silica microparticle gels as drug delivery vehicles","volume":"102","author":"Poluianova","year":"2024","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jconrel.2025.113602_bb0505","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1167\/iovs.12-11154","article-title":"Photosensitized oxidative stress to ARPE-19 cells decreases protein receptors that mediate photoreceptor outer segment phagocytosis","volume":"54","author":"Olchawa","year":"2013","journal-title":"Invest. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2025.113602_bb0510","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1021\/acs.molpharmaceut.5b00849","article-title":"A mechanistic model of the intravitreal pharmacokinetics of large molecules and the pharmacodynamic suppression of ocular vascular endothelial growth factor levels by Ranibizumab in patients with neovascular age-related macular degeneration","volume":"13","author":"Hutton-Smith","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.113602_bb0515","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1021\/j150516a002","article-title":"The solubility of amorphous silica in water","volume":"58","author":"Alexander","year":"1954","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.jconrel.2025.113602_bb0520","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1021\/ja02257a013","article-title":"The solubility of silica","volume":"39","author":"Lenher","year":"1917","journal-title":"J. Am. Chem. Soc."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925002111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925002111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:14:16Z","timestamp":1769220856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925002111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":103,"alternative-id":["S0168365925002111"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113602","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surface-coated silica microparticles: In vitro and ex vivo evaluation of a preclinical extended release platform conceived for intravitreal injection","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113602"}}